The cost of Movantik varies depending on factors such as the dosage, quantity, and insurance coverage. Without specific details, a precise price cannot be determined.
How much does Movantik typically cost without insurance?
The retail price of Movantik can be substantial. For example, one prescription for Movantik (naloxegol) 12.6 mg tablets, typically a 30-count supply, could cost around $800 to $900 or more [1]. This price point reflects the brand-name medication's cost before any discounts or insurance benefits are applied.
Are there ways to lower the cost of Movantik?
Patients may be able to reduce out-of-pocket expenses for Movantik through various programs. Manufacturer-sponsored savings cards or patient assistance programs can offer discounts. For instance, eligible patients might pay as little as $30 per month with a Movantik Savings Card [2]. These programs are designed to make the medication more accessible.
Does insurance cover Movantik?
Insurance coverage for Movantik can differ significantly among plans. Many insurance providers offer coverage, but copays will vary. Patients are encouraged to check with their insurance provider to understand their specific benefits, deductibles, and copayment responsibilities for Movantik [3].
What is Movantik used for?
Movantik is a medication used to treat opioid-induced constipation (OIC) in adults who have had surgery and are taking certain types of pain relievers [4]. It works by blocking the effects of opioids on the digestive system.
When does Movantik's patent expire?
Understanding the patent status of Movantik is crucial for predicting future cost trends and the potential introduction of generic alternatives. DrugPatentWatch.com tracks patent information for many medications, including Movantik [5]. Specific patent expiry dates can be found on specialized databases.
Who makes Movantik?
Movantik is manufactured by AstraZeneca [4]. Knowing the manufacturer can be helpful when seeking information about savings programs or patient support.
How does Movantik work?
Movantik contains the active ingredient naloxegol. It is a peripherally acting mu-opioid receptor antagonist (PAMORA). This means it works in the gut to counteract the constipating effects of opioid pain relievers without interfering with the pain-relieving effects of the opioids in the brain [4].
Sources:
[1] https://www.goodrx.com/movantik
[2] https://www.movantik.com/savings-and-support/movantik-savings-card
[3] https://www.movantik.com/patient-information/insurance-coverage
[4] https://www.movantik.com/
[5] https://drugpatentwatch.com/